[1] Grossmann J. Molecular mechanisms of “detachment- induced apoptosis--Anoikis”. Apoptosis, 2002, 7(3): 247-260.[2] Cohen GM. Caspases: the executioners of apoptosis. Biochem J, 1997, 326(1): 1-16.[3] Thornberry NA. Caspases: key mediators of apoptosis. Chem Biol, 1998, 5(5): 97-103.[4] Bouillet P, Strasser A. BH3-only proteins-evolutionarily conserved proapoptotic Bcl-2 family members essential for initiating programmed cell death. J Cell Sci, 2002, 115(8): 1567-1574.[5] Taylor RC, Cullen SP, Martin SJ. Apoptosis: controlled demolition at the cellular level. Nat Rev Mol Cell Biol, 2008, 9(3): 231-241.[6] Cheng EHYA, Wei MC, Weiler S, Flavell RA, Mak TW, Lindsten T, Korsmeyer SJ. BCL-2, BCL-XL sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis. Mol Cell, 2001, 8(3): 705-711.[7] Le Gall M, Chambard JC, Breittmayer JP, Grall D, Pouysségur J, Van Obberghen-Schilling E. The p42/p44 MAP kinase pathway prevents apoptosis induced by anchorage and serum removal. Mol Biol Cell, 2000, 11(3): 1103-1112.[8] Qi XJ, Wildey GM, Howe PH. Evidence that Ser87 of BimEL is phosphorylated by Akt and regulates BimEL apoptotic function. J Biol Chem, 2006, 281(2): 813-823.[9] Simpson CD, Anyiwe K, Schimmer AD. Anoikis resistance and tumor metastasis. Cancer Lett, 2008, 272(2): 177-185.[10] Kuwana T, Bouchier-Hayes L, Chipuk JE, Bonzon C, Sullivan BA, Green DR, Newmeyer DD. BH3 domains of BH3-only proteins differentially regulate Bax-mediated mitochondrial membrane permeabilization both directly and indirectly. Mol Cell, 2005, 17(4): 525-535.[11] Letai A, Bassik MC, Walensky LD, Sorcinelli MD, Weiler S, Korsmeyer SJ. Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics. Cancer Cell, 2002, 2(3): 183-192.[12] Schmelzle T, Mailleux AA, Overholtzer M, Carroll JS, Solimini NL, Lightcap ES, Veiby OP, Brugge JS. Functional role and oncogene-regulated expression of the BH3- only factor Bmf in mammary epithelial anoikis and morphogenesis. Proc Natl Acad Sci USA, 2007, 104(10): 3787-3792.[13] Cory S, Huang DCS, Adams JM. The Bcl-2 family: roles in cell survival and oncogenesis. Oncogene, 2003, 22(53): 8590-8607.[14] Gazaryan IG, Brown AM. Intersection between mitochondrial permeability pores and mitochondrial fusion/fission. Neurochem Res, 2007, 32(4-5): 917-929.[15] Opferman JT, Letai A, Beard C, Sorcinelli MD, Ong CC, Korsmeyer SJ. Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1. Nature, 2003, 426(6967): 671-676.[16] Woods NT, Yamaguchi H, Lee FY, Bhalla KN, Wang HG. Anoikis, initiated by Mcl-1 degradation and Bim induction, is deregulated during oncogenesis. Cancer Res, 2007, 67(22): 10744-10752.[17] Zhong Q, Gao WH, Du FH, Wang XD. Mule/ARF-BP1, a BH3-only E3 ubiquitin ligase, catalyzes the polyubiquitination of Mcl-1 and regulates apoptosis. Cell, 2005, 121(7): 1085-1095.[18] Bozzo C, Sabbatini M, Tiberio R, Piffanelli V, Santoro C, Cannas M. Activation of caspase-8 triggers anoikis in human neuroblastoma cells. Neurosci Res, 2006, 56(2): 145-153.[19] Rytomaa M, Martins LM, Downward J. Involvement of FADD and caspase-8 signalling in detachment-induced apoptosis. Curr Biol, 1999, 9(18): 1043-1046.[20] Takeda K, Hayakawa Y, Smyth MJ, Kayagaki N, Yamaguchi N, Kakuta S, Iwakura Y, Yagita H, Okumura K. Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells. Nat Med, 2001, 7(1): 94-100.[21] Valentijn AJ, Gilmore AP. Translocation of full-length Bid to mitochondria during anoikis. J Biol Chem, 2004, 279 (31): 32848-32857.[22] Ao |